Appears On
Episode Appearances
Bloomberg Intelligence · Jul 16, 2026
Lilly Strikes $3.8 Billion Deal for Psychedelic Drugmaker
“Covers healthcare, defense, industrials, autos; analyzed Eli Lilly psychedelic acquisition and pharma trends”
Psychedelic Drug Development and RegulationEli Lilly M&A Strategy and Contingent Value RightsPCSK9 Inhibitors and Cholesterol Management
View Analysis